Spots Global Cancer Trial Database for stage ii esophageal cancer
Every month we try and update this database with for stage ii esophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery | NCT00258297 | Esophageal Canc... | gefitinib conventional su... enzyme inhibito... neoadjuvant the... protein tyrosin... surgery | 18 Years - | University of Rochester | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002711 | Esophageal Canc... | chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | NCT00002951 | Esophageal Canc... Head and Neck C... | fluorouracil hydroxyurea surgical proced... radiation thera... | - | University of Chicago | |
| Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT00445861 | Esophageal Canc... | cetuximab + doc... Treatment level... Treatment level... conventional su... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | NCT00011960 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel adjuvant therap... radiation thera... | - | Radiation Therapy Oncology Group | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00003118 | Esophageal Canc... | cisplatin fluorouracil surgical proced... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | NCT00493025 | Esophageal Canc... | cisplatin gefitinib paclitaxel adjuvant therap... radiation thera... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | NCT00004235 | Esophageal Canc... Gastric Cancer | docetaxel irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | NCT00003087 | Esophageal Canc... | cisplatin paclitaxel surgical proced... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | NCT00316862 | Esophageal Canc... | cisplatin irinotecan hydr... therapeutic con... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer | NCT03708042 | Stage II Esopha... Stage III Esoph... | Definitive Radi... Neoadjuvant Rad... | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | NCT00493025 | Esophageal Canc... | cisplatin gefitinib paclitaxel adjuvant therap... radiation thera... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | NCT00002883 | Esophageal Canc... Gastric Cancer | cisplatin fluorouracil adjuvant therap... conventional su... neoadjuvant the... | 0 Years - 75 Years | UNICANCER | |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | NCT00003087 | Esophageal Canc... | cisplatin paclitaxel surgical proced... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | NCT00093652 | Esophageal Canc... | gefitinib oxaliplatin conventional su... neoadjuvant the... radiation thera... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer | NCT00711412 | Esophageal Canc... | Induction Thera... Induction Thera... Combination The... Combination The... Combination The... Evaluation for ... | 18 Years - 120 Years | Northwestern University | |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00030862 | Esophageal Canc... | cisplatin irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | NCT00002984 | Esophageal Canc... | cisplatin fluorouracil paclitaxel surgical proced... radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | NCT00006472 | Esophageal Canc... | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | - 120 Years | Medstar Health Research Institute | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | NCT00290719 | Esophageal Canc... | cisplatin gefitinib irinotecan hydr... conventional su... neoadjuvant the... radiation thera... | 18 Years - | University of California, San Francisco | |
| A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer | NCT02959385 | Stage II Esopha... Stage III Esoph... | Definitive Radi... Neoadjuvant Rad... | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | NCT00072033 | Esophageal Canc... | Cisplatin and D... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00021320 | Esophageal Canc... | cisplatin fluorouracil paclitaxel conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer | NCT00601692 | Esophageal Canc... | cisplatin docetaxel irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | NCT00008047 | Esophageal Canc... | fluorouracil hydroxyurea paclitaxel conventional su... radiation thera... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | NCT00004257 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | NCT00268437 | Esophageal Canc... | carboplatin Pemetrexed conventional su... neoadjuvant the... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | NCT00002897 | Esophageal Canc... | cisplatin fluorouracil conventional su... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | NCT00072033 | Esophageal Canc... | Cisplatin and D... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002711 | Esophageal Canc... | chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | NCT00086996 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer | NCT00100945 | Esophageal Canc... | gefitinib | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Irinotecan in Treating Patients With Esophageal or Stomach Cancer | NCT00003748 | Esophageal Canc... Gastric Cancer | irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00069953 | Esophageal Canc... | filgrastim pegfilgrastim cisplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus | NCT00003321 | Esophageal Canc... | psychosocial as... quality-of-life... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | NCT00281788 | Esophageal Canc... | capecitabine carboplatin paclitaxel radiation thera... | 18 Years - | Duke University | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | NCT00086996 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | NCT00354679 | Esophageal Canc... | bevacizumab cisplatin irinotecan hydr... proteomic profi... diagnostic labo... mass spectromet... adjuvant therap... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | NCT00052910 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil leucovorin calc... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002631 | Esophageal Canc... | chemotherapy cisplatin fluorouracil low-LET electro... low-LET photon ... | 18 Years - | Radiation Therapy Oncology Group | |
| Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT00445861 | Esophageal Canc... | cetuximab + doc... Treatment level... Treatment level... conventional su... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
| Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer | NCT00524121 | Esophageal Canc... | erlotinib hydro... immunohistochem... radiation thera... | 65 Years - 120 Years | Roswell Park Cancer Institute | |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
| Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | NCT00009880 | Esophageal Canc... Gastric Cancer | filgrastim cisplatin fluorouracil paclitaxel radiation thera... | - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | NCT00004897 | Esophageal Canc... | recombinant int... cisplatin fluorouracil hydroxyurea leucovorin calc... conventional su... radiation thera... | - | Northwestern University | |
| Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction | NCT00757172 | Adenocarcinoma ... Esophageal Canc... | panitumumab cisplatin docetaxel neoadjuvant the... therapeutic con... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach | NCT00003237 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel surgical proced... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | NCT00030498 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Ependymob... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Primary H... Adult Subependy... Advanced Adult ... Advanced Malign... Male Breast Can... Recurrent Adeno... Recurrent Adult... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Malig... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage II Esopha... Stage II Pancre... Stage III Esoph... Stage III Pancr... Stage IIIB Non-... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Bladde... Stage IV Breast... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Unspecified Adu... Untreated Metas... | erlotinib hydro... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | NCT00520091 | Esophageal Canc... | CPT- 11 Cisplatin Celecoxib Radiation Surgery | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | NCT00021047 | Esophageal Canc... Extrahepatic Bi... Gastric Cancer Head and Neck C... Liver Cancer Unspecified Adu... | capecitabine carboplatin epirubicin hydr... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer | NCT01254591 | Breast Cancer Colorectal Canc... Esophageal Canc... Head and Neck C... Lung Cancer | 18F-fluoromison... fluorescence an... laboratory biom... infrared thermo... magnetic resona... therapeutic con... [18F]-ML-10 fludeoxyglucose... rubidium Rb-82 | - | National Cancer Institute (NCI) | |
| Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer | NCT00033657 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... paclitaxel conventional su... radiation thera... | 18 Years - | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Positron Emission Tomography in Determining Stage of Esophageal Cancer | NCT00004867 | Esophageal Canc... | conventional su... positron emissi... radionuclide im... fludeoxyglucose... chemotherapy Radiotherapy | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer | NCT00238147 | Esophageal Canc... | capecitabine carboplatin docetaxel conventional su... neoadjuvant the... radiation thera... | 18 Years - | University of Washington | |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer | NCT00900094 | Breast Cancer Colorectal Canc... Esophageal Canc... Liver Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... | fluorescence in... polymerase chai... protein express... immunohistochem... laboratory biom... mass spectromet... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | NCT00047112 | Esophageal Canc... | cisplatin fluorouracil conventional su... neoadjuvant the... radiation thera... | - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Genetic and Environmental Risk Factors Related to Esophageal Cancer | NCT01035398 | Esophageal Canc... | 18 Years - 100 Years | Massachusetts General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
